在国家癌症数据库中调整人口差异以更好地代表美国癌症病例:研究人员的参考工具
Anays Murillo1,2, Kelsey S Romatoski1,2, Sophie H Chung1,2
1Section of Surgical Oncology, Department of Surgery, Boston Medical Center, Boston, MA, USA.
Annals of surgical oncology
|April 18, 2025
概括
国家癌症数据库 (NCDB) 显示,美国的癌症病例代表性正在改善,但不完整. 需要进行调整,以解决在特定的人口统计和地点的不足,以获得准确的癌症结局研究.
科学领域:
- 癌症研究 癌症研究
- 分析健康结果分析
- 数据库的使用情况.
背景情况:
- 国家癌症数据库 (NCDB) 是美国癌症结果研究的关键资源.
- 依靠癌症委员会批准的医院导致某些人群的代表性不足,并限制了概括性.
- 关于NCDB代表性的现有文献已经过时了,直到2014年.
研究的目的:
- 调整NCDB癌症病例,以更好地反映美国总癌症人口.
- 为改善NCDB数据对癌症结局研究的有用性提供一种方法.
主要方法:
- 将NCDB事件癌症病例 (2016-2020年) 与美国癌症统计局 (USCS) 综合数据库进行比较.
- 定义NCDB案例覆盖率作为在NCDB中代表的USCS案例的百分比.
- 对年龄,性别,种族/民族,居住地和癌症部位进行了分分析.
主要成果:
- 在5年 (2016-2020年) 中,NCDB覆盖率为70%,从68%增加到73%.
- 男性,85岁以上的个人,美国印第安人/阿拉斯加土著人和西班牙裔/拉丁裔个人 (分别为65%,59%,42%,55%) 的覆盖率最低.
- 山区 (49%) 和非大都会地区 (64%) 是代表性最低的地区;主要癌症类型的代表性也相似.
结论:
- NCDB对美国癌症病例的代表性正在改善,但仍存在重大差距.
- 在年龄,性别,种族/族裔和居住地之间存在代表性不足,缺失的数据加剧了这一现象.
- 该研究为研究人员提供了一种方法来调整NCDB数据,以便更定制的研究和结果框架.
相关概念视频
Cancer Survival Analysis
298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
Comparing the Survival Analysis of Two or More Groups
85
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
85
Statistical Methods for Analyzing Epidemiological Data
237
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
237
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K


